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ABSTRACT 
Background: Previous studies have reported that retinopathy might be present already in 
normoalbuminuric state in type 1 diabetes mellitus (T1DM). The aim of this study was to 
evaluate the risk factors for development and progression of nonproliferative retinopathy 
(NPR) in normoalbuminuric T1DM. 
Methods: A total of 223 T1DM with normal renal function and normoalbuminuria were 
included in this study and followed for 48 months. Photodocumented retinopathy status was 
made according to the EURODIAB protocol. Urinary albumin excretion rate (UAE) was 
measured from at least two 24-h urine samples. The possible risk factors for development or 
progression of NPR were examined in backward stepwise Cox's multiple regression analysis. 
Results: The majority of patients (70%) had no retinopathy while 67 (30%) had NPR at 
baseline. Patients with NPR were older, had longer duration of diabetes, higher systolic blood 
pressure, BMI, resting heart rate, UAE and lower estimated glomerular filtration rate (p≤0.04 
for all). After 48 months twenty-four patients (10.7%) developed NPR or progressed to 
proliferative retinopathy. Systolic blood pressure (HR 1.03, CI 1.01-1.05, p=0.02), UAE (HR 
1.14, CI 1.07-1.21, p<0.001), and resting heart rate (HR 1.05, CI 1.01-1.09, p=0.006) were 
significantly associated with development or progression of NPR. 
Conclusions: Our results suggest that retinopathy is present and may progress in T1DM even 
when coexisting renal disease is excluded. Normoalbuminuric T1DM require close 
monitoring for the early detection of retinopathy, especially if they have a higher UAE, 
systolic blood pressure and resting heart rate. 
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INTRODUCTION 
 It is well established that diabetic retinopathy is one of the leading causes of visual 
impairment and blindness in patients with type 1 diabetes [1]. Diabetic retinopathy is also 
associated with mortality and cardiovascular disease incidence in diabetes [2]. Prospective 
studies identified poor glycemic control, duration of diabetes and blood pressure as most 
important risk factors for development of retinopathy [3-7]. Retinopathy and nephropathy are 
most important microvascular complications in patients with diabetes. It is assumed that 
retinopathy and nephropathy occurs at the same time and that the severity of retinopathy 
parallels the presence and severity on nephropathy in diabetes mellitus [8,9]. In addition, it is 
suggested that relationship between renal abnormalities and retinopathy are more frequent in 
patients with type 1 diabetes than type 2 diabetes [10]. Nephropathy also had a strong effect 
on the associations between risk factors like dyslipidemia and retinopathy in type 1 diabetes 
[11]. However, it is still controversial whether albuminuria is independently associated with 
the incidence of diabetic retinopathy because several studies demonstrated that albuminuria is 
not a risk factor for diabetic retinopathy and that retinopathy might be present already in 
normoalbuminuric state in patients with type 1 diabetes [5,7,12-14]. Moreover, up to 27% of 
patients with type 1 diabetes with advanced retinopathy may be normoalbuminuric and even 
with normal glomerular structural measures determined with renal biopsy [15]. In patients 
with type 2 diabetes it has been documented that albuminuria is a risk factor for retinopathy 
even in normoalbuminuric state [16,17]. 
 The aim of this study was to evaluate the risk factors for development or progression 
of nonproliferative retinopathy (NPR) in normoalbuminuric patients with type 1 diabetes with 
glomerular filtration rate (GFR) > 60 ml min
-1 
1.73m
-2
. 
 
 
SUBJECTS, MATERIALS AND METHODS 
 Study included 223 patients with diabetes mellitus type 1, defined as an onset of 
diabetes before the age of 35 years, positive autoantibodies and permanent insulin treatment 
initiated within 1 year of diagnosis, who were referred to tertiary care specialist diabetes clinic 
between January 2005 and December 2012. The majority of patients were referred to clinic by 
general practitioners requiring assistance with surveillance and management of chronic 
complications of diabetes. Other patients were referred from other specialty units within 
clinic. Eligible participants were at least 18 years old, minimum duration of type 1 diabetes of 
1 year, no medical history of cardiovascular diseases or electrocardiogram (ECG) evidence of 
ischemic heart disease, absence of any systemic disease, and absence of any infections in the 
previous month. 
 All subjects were studied in the morning after an overnight fast. Basic anthropometric 
measurements were performed on all study subjects, including body mass index (BMI). Blood 
pressure was measured twice in the sitting position with a mercury sphygmomanometer and 
resting heart rate was determined using a standard 12-lead ECG, after a resting period of 10 
minutes. Urinary albumin excretion (UAE) was measured from at least two 24-h urine 
samples and determined as the mean of 24-h urine collections. Normoalbuminuria was 
defined as a UAE<30 mg/24h. Those with microalbuminuria (UAE≥30<300 mg/24h) and 
macroalbuminuria (UAE≥300 mg/24h) were excluded from the study. Data on serum 
creatinine levels, age, sex and race were used to calculate the estimated GFR using the 
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula, which has been 
shown to be accurate in determining renal function in diabetic patients with normal renal 
function [18,19]. Those with impaired estimated GFR (less than 60 ml min
-1
 1.73m
-2
)
 
were 
excluded from the study. All subjects were confirmed to be free of urinary tract infections. 
Retinopathy was diagnosed by binocular indirect slit lamp fundoscopy and fundus 
photography after mydriasis with eye drops containing 0.5% tropicamide and 5% 
phenylephrine. Color fundus photographs of two fields of both eyes were taken with a suitable 
45° fundus camera (VISUCAM, Zeiss) according to the EURODIAB retinal photography 
methodology [20]. EURODIAB classification scheme was used because it uses two-field 45° 
fundus photography and standard photographs to grade retinal lesions [20]. In each patient the 
"worse" eye was graded for retinopathy using fundus photographs. Those with proliferative 
retinopathy at baseline were excluded from the study. 
 Fasting venous blood samples were collected in the morning between 08:00 and 09:30 
hours after an overnight fast for the determination of HbA1c, total, LDL, HDL cholesterol, 
and triglycerides. Microalbumin and HbA1c was measured spectrophotometrically by 
turbidimetric immuno-inhibition (Olympus AU600, Beckman-Coulter, USA). Results of 
HbA1c (%) are expressed in the DCCT-equivalent. Glucose, cholesterol and triglycerides in 
serum were measured by an enzymatic colorimetric method (Olympus AU600, Beckman-
Coulter, USA). Complete blood count was determined on an automatic blood counter (Advia 
120, Siemens Diagnostic Solutions, USA). 
 The study protocol complies with the Declaration of Helsinki as well as with local 
institutional guidelines, and was approved by the local ethics committees. 
 
Statistical analysis 
Numeric variables are given as means (SD) or medians (ranges) depending on the normality 
distribution tested using Kolmogorov-Smirnov test, or percentages and absolute numbers for 
nominal variables. The unadjusted incidence rate was calculated by dividing the number of 
people with development or progression of NPR by the person years of follow up for the NPR 
development/progression and reported as events per 1000 persons for years of follow up. 
Follow up time was calculated from the beginning of the study to the first occurrence of that 
complication to the end of the study for those who did not have that complication. We 
calculated adjusted incidence rate of NPR development/progression using a Poisson 
regression model adjusted for sex, age and duration of diabetes and expressed in events per 
1,000 person per years of follow up. 
Cox's proportional hazards multiple regression analyses were used to examine the baseline 
variables predictive of development or progression of NPR, taking in account of potential 
confounders and pre-existing retinopathy. Results are described as relative risk (hazard ratio). 
A p value of less than 0.05 was regarded as significant. 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
RESULTS: 
 Baseline clinical and metabolic characteristics of patients with NPR and those without 
retinopathy are presented in Table 1. Patients with NPR were older, had longer duration of 
diabetes, higher BMI, systolic blood pressure, resting heart rate, UAE and lower estimated 
GFR compared to patients without retinopathy (p≤0.03 for all). 
 The majority of patients (70%) had no retinopathy while 67 (30%) had NPR at 
baseline. The mean UAE was 9.6 mg/24h and GFR estimated by the CKD-EPI was 108 ml 
min
-1
 1.73m
-2
 at baseline. After 48 months twenty-four patients (10.7%) developed NPR or 
progressed to proliferative retinopathy. From 156 patients free of retinopathy at the beginning 
of the study 15 (9.6%) progressed to NPR, while from 67 patients with NPR at the beginning 
of the study 9 (13.4%) progressed to proliferative retinopathy (Figure 1). The unadjusted 
incidence rate of retinopathy development/progression was 2.7 and the incidence rate adjusted 
for age, gender and disease duration was 1.904 (1.824-1.984) per 1,000 persons per year. 
 The possible risk factors for development or progression of NPR were examined in 
backward stepwise Cox's multiple regression analysis (Table 2). Systolic blood pressure, 
UAE and resting heart rate were significantly associated with development or progression of 
NPR. An increase in 1 mg/24h of UAE was associated with a risk of 14,3% (95% confidence 
interval 7-21%).  
 
 
 
 
 
DISCUSSION 
 It is assumed that retinopathy and nephropathy, as most important microvascular 
complications in diabetes, occurs at the same time although previous studies documented that 
retinopathy might be present already in normoalbuminuric state in patients with type 1 
diabetes [5,7,12,14]. The prevalence of NPR at the beginning of the study in our patients was 
30%, which is much lower to the prevalence of retinopathy reported in previous studies 
including normoalbuminuric patients with type 1 diabetes [5,6, 21]. After 48 months of 
following, UAE, systolic blood pressure and resting heart rate were risk factors for 
development or progression of NPR in our normoalbuminuric patients with type 1 diabetes. 
 Resting heart rate is an independent predictor of all-cause death and major 
cardiovascular complications in subjects with and without diabetes [22]. Higher heart rate 
might promote higher UAE, indicating endothelial dysfunction, which are important factors in 
the development of retinopathy and nephropathy [23]. However, it seems that relation 
between resting heart rate and the risk of retinopathy is stronger than the association with 
nephropathy in diabetes [24]. In addition, it has been shown that resting heart rate is 
independently associated with retinopathy in patients with type 1 and 2 diabetes, even in those 
with normoalbuminuria [16, 24, 25].  
 Relationship between hypertension and retinopathy in type 1 diabetes is still 
controversial. It has been documented that hypertensive normoalbuminuric patients with type 
1 diabetes had no higher prevalence of retinopathy compared to normoalbuminuric 
normotensive patients [26]. In addition, blood pressure is similar in normotensive 
normoalbuminuric patients with type 2 diabetes with and without retinopathy [27]. Another 
study of normoalbuminuric patients with type 1 diabetes found higher only night blood 
pressure in patients with retinopathy compared to those without retinopathy [5]. However, 
results from EURODIAB study found that diastolic blood pressure is significant risk factor 
for retinopathy in type 1 diabetes after adjusting for UAE, while nighttime systolic 24-hour 
ambulatory blood pressure was associated with presence and severity of retinopathy in 
normotensive patients with type 1 diabetes without nephropathy [6, 28]. In our study only 
systolic blood pressure was associated with risk of progression of retinopathy, and the 
prospective UKPDS study also found higher relative risk for incidence of retinopathy with 
higher systolic blood pressure in type 2 diabetes [29]. However, methods used for diagnosis 
of blood pressure (single standard sphygmomanometer not 24-hour ambulatory blood 
pressure) may influence on final results in our investigation. 
 Of all factors studied, UAE has the strongest impact on retinopathy development and 
progression. UAE could predict the presence and progression of retinopathy even in 
normoalbuminuric patients with type 1 diabetes. It has been documented that some patients 
with advanced retinopathy have normal UAE and glomerular morphology determined with 
renal biopsy [15]. However, in most subjects a normal UAE does not imply normal renal 
function and does not exclude glomerular barrier damage because normoalbuminuric patients 
with type 1 diabetes and retinopathy have preclinical renal morphologic changes, higher 
urinary IgG2, IgG4 excretion and higher IgG2/creatinine and IgG2/IgG4 ratios compared to 
the patients without retinopathy [6, 21, 30]. Moreover, the cutt-off point for microalbuminuria 
is based on findings from studies in the 1980s in which the progression rate to nephropathy 
was very high in patients with values of UAE of 30 mg/24h [31]. In patients with type 2 
diabetes it has been documented that UAE threshold of 10.7 mg/24, which are in 
normoalbuminuric range, could predict the increase risk for diabetic retinopathy and that the 
severity of retinopathy is aggravated with an increasing of UAE in normoalbuminuric range 
[17, 32]. In multiple regression analyses UAE was strongest variable that predict progression 
to incipient or progression to proliferative retinopathy confirming previous observations that 
retinal microvascular abnormalities are associated with renal dysfunction independently of 
age, diabetes, hypertension and other risk factors [33]. 
 In conclusion, our results suggest that retinopathy is present and may progress in 
patients with type 1 diabetes even when coexisting renal disease is excluded. This points to 
the need for close monitoring of normoalbuminuric patients with type 1 diabetes aimed at 
early detecting, preventing or limiting the progression of NPR, especially in patients with 
higher UAE, systolic blood pressure and higher resting heart rate. However, this study used a 
convenience sample of patients with type 1 diabetes recruited at one of their regularly 
scheduled diabetes appointment and it is possible that the results may not generalize to all 
patients with type 1 diabetes. 
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Figure 1. Number of patients that developed nonproliferative retinopathy or progressed to 
proliferative retinopathy during follow up 
 
 
 
 
 
 
 
 
Table 1: Baseline clinical and metabolic characteristics of patients without and with 
nonproliferative retinopathy (NPR) 
                                    without NPR (n=156)  with NPR (n=67)             P 
Age (years)                39 (20-65)               49 (24-67)                <0.001 
Sex (m/f)                              83/73                       34/33                          0.7 
Duration of diabetes (years)14±8                        24±9                        <0.001          
Body mass index (kg/m
2
)    24 (18-38)                25 (19-35)                  0.04 
HbA1c (%)                          6.9±1.4                    7.2±1.5                       0.2 
SBP (mmHg)                      120 (80-180)            130 (95-160)               0.03    
DBP (mmHg)                      80 (60-110)              80 (50-110)                0.5 
Heart rate (beats/min)         70 (51-98)                74 (44-111)                0.001  
LDL cholesterol (mmol/L)  2.8±0.7                    3.0±0.9                       0.2 
HDL cholesterol (mmol/L)  1.7±0.4                    1.7±0.4                       0.9 
Triglycerides (mmol/L)      0.98±0.6                  1.13±0.7                     0.07 
Serum creatinine (µmol/L)   70±11                      71±13                        0.4 
eGFR (ml min
-1
 1.73m
-2
)     108±13                    101±17                      0.001 
UAE (mg/24h)                     7.8 (2.3-25.5)          10.3 (1.3-29)             0.006 
Smoking (yes/no, %)            55/101                     26/41                         0.6            
Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; 
eGFR, estimated glomerular filtration rate; UAE, urinary albumin excretion 
rate.  
 
 
 
 
 
 
 
 
 
 
Table 2: Cox's multiple regression analysis model by means of baseline risk factors for 
development or progression of diabetic retinopathy  
Variable Relative risk (95% CI) P value 
Age 1.02 (0.95-1.09) 0.5 
Duration of diabetes 0.98 (0.92-1.05) 0.7 
Body mass index 0.95 (0.84-1.07) 0.4 
Systolic blood pressure  1.03 (1.01-1.05) 0.02 
Resting heart rate  1.05 (1.01-1.09) 0.006 
Pre-existing retinopathy 0.67 (0.20-2.19) 0.5 
Urinary albumin excretion 1.14 (1.07-1.21) < 0.001 
Estimated GFR 1.01 (0.97-1.06) 0.4 
 
